Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
25.26
+0.46 (1.85%)
At close: Jun 6, 2025, 4:00 PM
25.20
-0.06 (-0.24%)
After-hours: Jun 6, 2025, 4:09 PM EDT

Astrana Health Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Astrana Health stock ranges from a low of $36 to a high of $70. The average analyst price target of $53.29 forecasts a 110.97% increase in the stock price over the next year.

Price Target: $53.29 (+110.97%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $36 $53.29 $50 $70
Change +42.52% +110.97% +97.94% +177.12%
* Price targets were last updated on Apr 1, 2025.

Analyst Ratings

The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 445555
Buy 111111
Hold 111222
Sell 000000
Strong Sell 000000
Total 667888

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Barclays
Barclays
Hold
Initiates
$36
Hold Initiates $36 +42.52% Apr 1, 2025
Truist Securities
Truist Securities
Strong Buy
Maintains
$50$46
Strong Buy Maintains $50$46 +82.11% Mar 18, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$55$49
Strong Buy Maintains $55$49 +93.98% Mar 4, 2025
Baird
Baird
Buy
Maintains
$86$50
Buy Maintains $86$50 +97.94% Mar 3, 2025
Stifel
Stifel
Strong Buy
Maintains
$70$56
Strong Buy Maintains $70$56 +121.69% Feb 20, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
2.74B
from 2.03B
Increased by 34.87%
Revenue Next Year
3.34B
from 2.74B
Increased by 21.61%
EPS This Year
1.25
from 0.90
Increased by 38.78%
EPS Next Year
1.63
from 1.25
Increased by 30.39%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
687.18M773.92M1.14B1.39B2.03B2.74B3.34B3.98B
Revenue Growth
22.58%12.62%47.84%21.19%46.72%34.87%21.61%19.24%
EPS
1.011.520.991.290.901.251.632.52
EPS Growth
158.97%50.50%-34.87%30.30%-30.23%38.78%30.39%54.95%
Forward PE
-----20.2215.5110.01
No. Analysts
-----14126
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 3.4B 4.3B 4.7B
Avg 2.7B 3.3B 4.0B
Low 2.5B 2.8B 3.3B

Revenue Growth

Revenue Growth 202520262027
High
65.0%
55.8%
42.3%
Avg
34.9%
21.6%
19.2%
Low
21.8%
2.1%
-0.1%

EPS Forecast

EPS 202520262027
High 1.96 2.56 3.80
Avg 1.25 1.63 2.52
Low 0.80 0.33 0.90

EPS Growth

EPS Growth 202520262027
High
118.3%
104.7%
133.1%
Avg
38.8%
30.4%
55.0%
Low
-10.7%
-73.5%
-44.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.